Cassava Sciences Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
SAVA Nasdaq 8731 https://www.cassavasciences.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Cassava Sciences Inc

SAVA Stock Down on Settling Misleading Alzheimer's Study Data Claims - Sep 30th, 2024 2:05 pm
Company News for Sep 30, 2024 - Sep 30th, 2024 1:18 pm
Why Cassava Sciences Stock Dived by Almost 11% Today - Sep 27th, 2024 10:05 pm
These Stocks Moved the Most Today: Bristol Myers, Costco, EchoStar, Cassava, DJT, Wynn, HP Inc., Acadia Healthcare, and More - Sep 27th, 2024 8:38 pm
Cassava Sciences agrees to $40M SEC fine over Alzehimer's claims - Sep 27th, 2024 7:36 pm
Top Midday Decliners - Sep 27th, 2024 5:58 pm
Cassava's Stock Drops After It Agrees to Pay $40M to Settle SEC Alzheimer's Claims - Sep 27th, 2024 2:10 pm
Cassava Sciences shares drop in pre-open trade after $40 mln SEC settlement - Sep 27th, 2024 12:48 pm
SEC Charges Cassava Sciences Over Manipulated Alzheimer's Trial Data, Company And Former Execs Agree To Pay Penalty - Sep 27th, 2024 12:28 pm
Update: Cassava Sciences Pays $40 Million to Settle SEC Charges; Shares Drop Pre-Bell - Sep 27th, 2024 9:42 am
Cassava to Pay $40 Million to SEC Over Alzheimer’s Drug Claims - Sep 26th, 2024 11:11 pm
Cassava Sciences Resolves SEC Investigation - Sep 26th, 2024 10:15 pm
Cassava Sciences shares fall after SEC charges for misleading Alzheimer's drug trial claims - Sep 26th, 2024 9:46 pm
Eli Lilly Secures Approval for Alzheimer's Drug Kisunla in Japan - Sep 25th, 2024 3:45 pm
Cassava Sciences Announces Completion of an Interim Safety Review of Oral Simufilam On-going Phase 3 Trials - Sep 24th, 2024 12:30 pm
Cassava Sciences Names Rick Barry as Chief Executive Officer - Sep 9th, 2024 12:30 pm
Cassava Sciences to Present at the H.C. Wainwright Global Investment Conference - Sep 3rd, 2024 12:31 pm
Silicon Motion Technology Corporation (SAVA): Evaluating Its Position Among Top Debt-Free Stocks - Aug 18th, 2024 2:44 am
Cassava Sciences, Inc. (NASDAQ:SAVA): Is Breakeven Near? - Aug 10th, 2024 1:09 pm
Cassava Sciences Reports Q2 2024 Financial Results and Operational Updates - Aug 8th, 2024 12:00 pm